Researchers from North Carolina State University, the University of North Carolina at Chapel Hill and First Affiliated Hospital of Zhengzhou University have developed a synthetic version of a cardiac stem cell. These synthetic stem cells offer therapeutic benefits comparable to those from natural stem cells and could reduce some of the risks associated with stem cell therapies. Additionally, these cells have better preservation stability and the technology is generalizable to other types of stem cells.
Stem cell therapies work by promoting endogenous repair; that is, they aid damaged tissue in repairing itself by secreting “paracrine factors,” including proteins and genetic materials. While stem cell therapies can be effective, they are also associated with some risks of both tumor growth and immune rejection. Also, the cells themselves are very fragile, requiring careful storage and a multi-step process of typing and characterization before they can be used.
Ke Cheng, associate professor of molecular biomedical sciences at NC State, associate professor in the joint biomedical engineering program at NC State and UNC, and adjunct associate professor at the UNC Eshelman School of Pharmacy, led a team in developing the synthetic version of a cardiac stem cell that could be used in off-the-shelf applications.
Cheng and his colleagues fabricated a cell-mimicking microparticle (CMMP) from poly (lactic-co-glycolic acid) or PLGA, a biodegradable and biocompatible polymer. The researchers then harvested growth factor proteins from cultured human cardiac stem cells and added them to the PLGA. Finally, they coated the particle with cardiac stem cell membrane.
“We took the cargo and the shell of the stem cell and packaged it into a biodegradable particle,” Cheng says.
When tested in vitro, both the CMMP and cardiac stem cell promoted the growth of cardiac muscle cells. They also tested the CMMP in a mouse model with myocardial infarction, and found that its ability to bind to cardiac tissue and promote growth after a heart attack was comparable to that of cardiac stem cells. Due to its structure, CMMP cannot replicate – reducing the risk of tumor formation.
“The synthetic cells operate much the same way a deactivated vaccine works,” Cheng says. “Their membranes allow them to bypass the immune response, bind to cardiac tissue, release the growth factors and generate repair, but they cannot amplify by themselves. So you get the benefits of stem cell therapy without risks.”
The synthetic stem cells are much more durable than human stem cells, and can tolerate harsh freezing and thawing. They also don’t have to be derived from the patient’s own cells. And the manufacturing process can be used with any type of stem cell.
“We are hoping that this may be a first step toward a truly off-the-shelf stem cell product that would enable people to receive beneficial stem cell therapies when they’re needed, without costly delays,” Cheng says.
Receive an email update when we add a new STEM CELLS article.
The Latest on: Stem cells
via Google News
The Latest on: Stem cells
- Stem cells may give a respite to COVID-19 infectedon March 23, 2020 at 10:07 am
While stem cell treatment is not a technique to eradicate or fix coronavirus completely, there is proof to help the idea that infected patients, under the treatment, might be more receptive to survive ...
- Stem cells and nerves interact in tissue regeneration and cancer progressionon March 23, 2020 at 8:42 am
Stem cells can generate a variety of specific tissues and are increasingly used for clinical applications such as the replacement of bone or cartilage. However, stem cells are also present in ...
- How 'pioneer' protein turns stem cells into organson March 23, 2020 at 8:33 am
Early on in each cell, a critical protein known as FoxA2 simultaneously binds to both the chromosomal proteins and the DNA, opening the flood gates for gene activation, according to a new study. The ...
- Immunotherapy using 'young cells' offers promising option against canceron March 23, 2020 at 6:21 am
opening the door to the possibility of an immunotherapy that would not utilize cells from the patient or a matched donor. Instead, they could be developed from existing supplies of what are called ...
- Stem cells establish contacts with nerves in tissue regeneration and cancer progressionon March 23, 2020 at 5:13 am
Researchers at the University of Zurich show that different stem cell populations are innervated in distinct ways. Innervation may therefore be crucial for proper tissue regeneration. They also ...
- Low rates of mutation in clinical grade human pluripotent stem cells under different culture conditionson March 23, 2020 at 3:16 am
and whether any form during culture prior to use in a human clinical context are a concern. Here, the authors use hPSCs derived to cGMP standards and show they have low mutation rates after culture, ...
- Dynamical reorganization of the pluripotency transcription factors Oct4 and Sox2 during early differentiation of embryonic stem cellson March 23, 2020 at 3:09 am
Pluripotency maintenance requires transcription factors (TFs) that induce genes necessary to preserve the undifferentiated state and repress others involved in differentiation. Recent observations ...
- Induced Pluripotent Stem Cells Market - 2020 Size, Trends, Share, Key Players, Statistics, And Regional Forecast To 2026on March 23, 2020 at 1:57 am
Induced Pluripotent Stem Cells Market 2020 Global Size, Share, Trends Analysis With Forecast To 2026. Report provides Global Induced Pluripotent Stem Cells Market Insights, Segments Overview with Key ...
- Human Embryonic Stem Cells (HESC) Market Segmentation and Analysis by Recent Trends, Development and Growth by Regions to 2024on March 22, 2020 at 8:09 am
Global “Human Embryonic Stem Cells (HESC)Market“ Report 2020report recorddetailed estimation to improvement a complete information of the global Human Embryonic Stem Cells (HESC) market today and its ...
via Bing News